These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 10329577

  • 21. A poliovirus-susceptible transgenic mouse model as a possible replacement for the monkey neurovirulence test of oral poliovirus vaccine.
    Dragunsky E, Taffs R, Chernokhvostova Y, Nomura T, Hioki K, Gardner D, Norwood L, Levenbook I.
    Biologicals; 1996 Jun; 24(2):77-86. PubMed ID: 8889053
    [Abstract] [Full Text] [Related]

  • 22. Neurovirulence of Sabin 1-derived polioviruses isolated from an immunodeficient patient with prolonged viral excretion.
    Yoneyama T, Yoshida H, Shimizu H, Yoshii K, Nagata N, Kew O, Miyamura T.
    Dev Biol (Basel); 2001 Jun; 105():93-8. PubMed ID: 11763343
    [Abstract] [Full Text] [Related]

  • 23. Detection of mutants in polio vaccine viruses using pooled antipoliovirus monoclonal antibodies.
    Horie H, Sato-Miyazawa M, Ota Y, Wakabayashi K, Doi T, Yoshizawa K, Doi Y, Hashizume S.
    Biologicals; 1999 Sep; 27(3):217-26. PubMed ID: 10652177
    [Abstract] [Full Text] [Related]

  • 24. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
    Kohara M, Abe S, Komatsu T, Tago K, Arita M, Nomoto A.
    J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in Hungary.
    Kapusinszky B, Molnár Z, Szomor KN, Berencsi G.
    FEMS Immunol Med Microbiol; 2010 Mar; 58(2):211-7. PubMed ID: 19863665
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.
    Crainic R, Blondel B, Candréa A, Dufraisse G, Horaud F.
    Dev Biol Stand; 1985 Mar; 60():343-7. PubMed ID: 2995173
    [Abstract] [Full Text] [Related]

  • 36. Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype.
    Kawamura N, Kohara M, Abe S, Komatsu T, Tago K, Arita M, Nomoto A.
    J Virol; 1989 Mar; 63(3):1302-9. PubMed ID: 2536835
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.